Skip to Main Content

Publication Cover

Xenobiotica

the fate of foreign compounds in biological systems

Volume 52, 2022 - Issue 6

987

Views

1

CrossRef citations to date

0

Altmetric

Clinical Pharmacokinetics and Metabolism

A population pharmacokinetic-pharmacodynamic model of navtemadlin, its glucuronide metabolite (M1) and serum macrophage inhibitory cykokine-1 (MIC-1)

Lu Zhanga Certara Integrated Drug Development, Princeton, NJ, USAView further author information

,

Bill Polanda Certara Integrated Drug Development, Princeton, NJ, USAView further author information

,

Michelle Greena Certara Integrated Drug Development, Princeton, NJ, USAView further author information

,

Shekman Wongb Kartos Therapeutics, Inc., Redwood City, CA, USA;c Kartos Therapeutics, Inc., Bellevue, WA, USAView further author information

&

J. Greg Slatterb Kartos Therapeutics, Inc., Redwood City, CA, USA;c Kartos Therapeutics, Inc., Bellevue, WA, USACorrespondence[email protected]
View further author information